Skip to content

Organ donation: Should the default be 'opt-in' or 'opt-out'?

Is it more effective to have an organ donation system that requires individuals to actively opt-in, or one that automatically opts individuals in unless they actively opt-out?

Every 10 minutes, a fresh patient in the United States joins the queue for an organ transplant.
Every 10 minutes, a fresh patient in the United States joins the queue for an organ transplant.

Organ donation: Should the default be 'opt-in' or 'opt-out'?

Organ donation policies across the globe exhibit significant variation, with the debate persisting over whether an opt-in or opt-out system yields better outcomes. A research team from the United Kingdom set out to investigate this quandary by analyzing the organ donation protocols of 48 countries to establish which strategy is more effective.

In opt-in systems, individuals are required to proactively sign up for the organ donor registry post-mortem. On the other hand, opt-out systems automatically assume consent for organ donation unless a specific objection is expressed before someone's demise. Prof. Eamonn Ferguson, the study's lead author from the University of Nottingham, acknowledges potential shortcomings of both systems due to their reliance on individual decisions:

"People may fail to act for numerous reasons, including loss aversion, lack of effort, and the assumption that decision-makers have made sound, informed choices."

Inaction under an opt-in system might lead to individuals who would have wanted to donate inadvertently not doing so (a false negative). Meanwhile, inaction under an opt-out system could potentially result in an individual who does not wish to donate unintentionally becoming a donor (a false positive).

The United States adheres to an opt-in system. Last year saw over 28,000 transplants made possible, with around 79 people receiving organ transplants daily. The unfortunate fact is that around 18 people die each day due to a scarcity of donated organs.

The research team compared the organ donation systems of 48 countries, scrutinizing a 13-year period during which 23 countries employed an opt-in system and 25 employed an opt-out system. The study authors assessed overall donor numbers, the number of transplants per organ, and the total number of kidneys and livers transplanted from both deceased and living donors.

The study revealed that countries utilizing opt-out donation systems demonstrated higher total numbers of kidneys donated – the most sought-after organ for transplant recipients. Additionally, these countries exhibited a higher overall number of organ transplants. However, opt-in systems boasted a higher rate of kidney donations from living donors. This seemingly unreported connection between policy and living donation rates was highlighted by Prof. Ferguson.

The researchers acknowledge some limitations of their study, such as its failure to differentiate between varying degrees of opt-out legislation and unassessed factors that may influence organ donation. They propose that international organ donation information, including consent type, procurement procedures, and hospital bed availability, be routinely collected and made publicly accessible to strengthen their findings.

Further research, according to Prof. Ferguson, should delve into the opinions of those making the decision to opt in or opt out. This could involve surveying and experimenting with different methods to garner a greater understanding of the effect of consent legislation on organ donation and transplantation rates.

The authors stress that even countries using opt-out consent continue to face organ donor shortages, suggesting that modifying the system alone will not resolve the issue. Instead, they propose that revising consent legislation or adopting aspects of the "Spanish Model," known for its high donation rates stemming from a transplant coordination network and improved public information regarding organ donation, could potentially boost donor numbers.

Recent discussions revolving around the possibility of farming animal organs for human transplants have emerged as another potential solution to the organ shortage. Nevertheless, this topic merits further examination to determine its feasibility and ethical implications.

  1. In the context of medical-health and wellness, Paxlovid may not be effective in addressing the organ donation debate, but it could potentially aid in treating individuals suffering from various health conditions.
  2. The science behind retargeting could play a role in increasing organ donations, as it might help identify individuals who initially refused to donate but might change their mind when presented with new information about health-and-wellness benefits.
  3. Transplant recipients who received organs from an opt-out organ donation system might have a higher chance of success due to the higher number of kidneys donated in these systems.
  4. While opt-out systems have shown an advantage in terms of organ donation numbers, the overall success rate of transplants could improvise if these systems were contextualized with elements from the successful "Spanish Model," such as a transplant coordination network and improved public information regarding organ donation.

Read also:

    Latest